X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (258) 258
fc-gamma-riiia (254) 254
index medicus (219) 219
rituximab (119) 119
immunology (105) 105
animals (99) 99
oncology (88) 88
female (81) 81
dependent cellular cytotoxicity (76) 76
receptors, igg - genetics (70) 70
anti-cd20 monoclonal-antibody (69) 69
binding (67) 67
monoclonal-antibody (67) 67
chronic lymphocytic-leukemia (66) 66
antibodies, monoclonal - therapeutic use (65) 65
cancer (64) 64
male (62) 62
hematology (56) 56
non-hodgkins-lymphoma (55) 55
killer cells, natural - immunology (53) 53
adcc (51) 51
cytotoxicity (51) 51
adult (50) 50
glycosylation (49) 49
middle aged (49) 49
monoclonal antibodies (49) 49
antibodies (47) 47
natural-killer-cells (47) 47
polymorphism (46) 46
immunotherapy (45) 45
antibodies, monoclonal - pharmacology (44) 44
antibody-dependent cell cytotoxicity (44) 44
medicine, research & experimental (42) 42
follicular lymphoma (41) 41
genotype (41) 41
immunoglobulin-g (40) 40
aged (39) 39
biochemistry & molecular biology (39) 39
igg (39) 39
mice (39) 39
fc receptors (38) 38
antineoplastic agents - therapeutic use (37) 37
fcγriiia (37) 37
in-vivo (37) 37
antibodies, monoclonal - immunology (36) 36
antibodies, monoclonal, murine-derived (36) 36
in-vitro (36) 36
rheumatoid-arthritis (36) 36
cell line, tumor (35) 35
fc gamma riiia (34) 34
receptors, igg - metabolism (34) 34
gamma-riiia (33) 33
lymphomas (33) 33
analysis (32) 32
antigens, cd20 - immunology (32) 32
immunoglobulin g (32) 32
biotechnology & applied microbiology (31) 31
c-receptor polymorphisms (31) 31
treatment outcome (31) 31
health aspects (30) 30
pharmacology & pharmacy (30) 30
antibody (29) 29
expression (29) 29
fucose (29) 29
receptors, igg - immunology (29) 29
polymorphism, genetic (28) 28
research (28) 28
therapeutic antibodies (28) 28
antibody-dependent cell cytotoxicity - drug effects (26) 26
immunoglobulin g - immunology (26) 26
viral antibodies (26) 26
antibody-dependent cell cytotoxicity - immunology (25) 25
care and treatment (25) 25
chemotherapy (24) 24
antineoplastic agents - pharmacology (23) 23
b-cell lymphoma (23) 23
clinical trials as topic (23) 23
effector functions (23) 23
predict response (23) 23
activation (22) 22
b-lymphocytes - immunology (22) 22
flow cytometry (22) 22
genetic aspects (22) 22
nk cells (22) 22
monoclonal antibody (21) 21
systemic-lupus-erythematosus (21) 21
t-cells (21) 21
antibody-dependent cellular cytotoxicity (20) 20
antineoplastic combined chemotherapy protocols - therapeutic use (20) 20
cell biology (20) 20
monoclonal-antibodies (20) 20
natural killer cells (20) 20
proteins (20) 20
antibodies, monoclonal - chemistry (19) 19
antiinflammatory activity (19) 19
human igg1 (19) 19
killer cells, natural - metabolism (19) 19
polymorphism, single nucleotide (19) 19
therapeutic activity (19) 19
antibodies, monoclonal, humanized (18) 18
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Biochemistry, ISSN 0006-2960, 05/2015, Volume 54, Issue 19, pp. 2931 - 2942
Journal Article
Blood, ISSN 0006-4971, 10/2007, Volume 110, Issue 7, pp. 2561 - 2564
The presence of valine (V) at position 158 of Fc-gamma Rllla (CD16) is known to improve clinical response to rituximab in indolent non-Hodgkin lymphoma (NHL).... 
PREDICT RESPONSE | ANTI-CD20 MONOCLONAL-ANTIBODY | FC-GAMMA-RIIIA | HUMAN-IGG | NON-HODGKINS-LYMPHOMA | HEMATOLOGY | CLINICAL-RESPONSE | Immunobiology
Journal Article
AIDS, ISSN 0269-9370, 11/2011, Volume 25, Issue 17, pp. 2099 - 2104
Objectives: To determine the effect of IgG2 opsonization on internalization of HIV-1 virus-like particles (VLPs) by monocytes and to determine the effect of... 
phagocytosis | INFECTIOUS DISEASES | NATURAL-KILLER-CELLS | glycosylation | ANTIBODY | IMMUNOLOGY | Fc gamma receptors | EFFECTOR-CELLS | FC-RECEPTOR | IN-VITRO | STREPTOCOCCUS-PNEUMONIAE | VIROLOGY | IgG subclass | IMMUNODEFICIENCY-VIRUS TYPE-1 | gp120 | opsonization | antibodies | INFECTION | GAMMA RIIIA CD16 | DEPENDENT ENHANCEMENT
Journal Article
mAbs, ISSN 1942-0862, 08/2017, Volume 9, Issue 6, pp. 968 - 977
As biosimilars enter the market, comparisons of product quality are needed. Manufacturing differences may lead to differences in critical quality attributes,... 
Fc glycosylation | critical quality attributes | infliximab | Antibody-dependent cell-mediated cytotoxicity | biosimilar | FcγRIIIa binding | MEDICINE, RESEARCH & EXPERIMENTAL | FC GLYCANS | Fc gamma RIIIa binding | THERAPEUTIC ANTIBODIES | ADCC ACTIVITY | FUCOSE | DEPENDENT CELLULAR CYTOTOXICITY | BINDING
Journal Article
Journal of Immunological Methods, ISSN 0022-1759, 03/2010, Volume 354, Issue 1-2, pp. 20 - 33
The efficacy of a therapeutic IgG molecule may be as dependent on the optimisation of the constant region to suit its intended indication as on the selection... 
FcγRIIIa | Monoclonal antibody | Immunotherapy | Antibody-dependent cell-mediated cytotoxicity | V/F POLYMORPHISM | NATURAL-KILLER-CELLS | BIOCHEMICAL RESEARCH METHODS | IMMUNOLOGY | PREDICT RESPONSE | Fc gamma RIIIa | ANTI-CD20 MONOCLONAL-ANTIBODY | ALPHA-BLOCKING AGENTS | NK CELLS | RITUXIMAB | IN-VIVO | CHRONIC LYMPHOCYTIC-LEUKEMIA | C-RECEPTOR POLYMORPHISMS
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 04/2013, Volume 19, Issue 7, pp. 1858 - 1872
Purpose: Tumor antigen-specific monoclonal antibodies (mAb) block oncogenic signaling and induce Fc gamma receptor (Fc gamma R)-mediated cytotoxicity. However,... 
BREAST-CANCER | PREDICT RESPONSE | CONCURRENT RADIOTHERAPY | NK CELLS | ONCOLOGY | FC-GAMMA-RIIIA | EGFR EXPRESSION | CHRONIC LYMPHOCYTIC-LEUKEMIA | NON-HODGKINS-LYMPHOMA | ANTIBODY | C-RECEPTOR POLYMORPHISMS | Coculture Techniques | Dendritic Cells - immunology | Humans | Middle Aged | Antibody-Dependent Cell Cytotoxicity - immunology | Male | Th1 Cells - immunology | Th1 Cells - metabolism | Receptors, IgG - genetics | NK Cell Lectin-Like Receptor Subfamily K - metabolism | ATP-Binding Cassette Transporters - metabolism | Killer Cells, Natural - immunology | Female | Cetuximab | Dendritic Cells - metabolism | T-Lymphocytes, Cytotoxic - immunology | Receptor, Epidermal Growth Factor - immunology | Antibodies, Monoclonal, Humanized - therapeutic use | Antigens, Neoplasm - immunology | Lymphocyte Activation | Interferon-gamma - secretion | Head and Neck Neoplasms - drug therapy | Genotype | Receptors, IgG - immunology | Head and Neck Neoplasms - pathology | Polymorphism, Genetic | Receptor Cross-Talk - immunology | Head and Neck Neoplasms - immunology | Cross-Priming - immunology | Cell Line, Tumor | Head and Neck Neoplasms - genetics | T-Lymphocytes - immunology | Aged | Head and Neck Neoplasms - mortality | Killer Cells, Natural - metabolism | Antibodies, Monoclonal, Humanized - immunology | Neoplasm Staging | ATP-Binding Cassette Sub-Family B Member 2 | Cytokines - biosynthesis | cross-presentation | head and neck cancer | Panitumumab | immunotherapy | CTL | ADCC | EGFR
Journal Article
The Journal of Immunology, ISSN 0022-1767, 01/2006, Volume 176, Issue 1, pp. 346 - 356
Journal Article
Journal of Proteome Research, ISSN 1535-3893, 07/2011, Volume 10, Issue 7, pp. 3031 - 3039
Journal Article